Table 4 |
||||||
|
Agreement table of diagnostic groups basis on D-Score |
||||||
|
D-Score(O1T1) |
D-Score(O2T1) |
D-Score(O3T1) |
||||
|
≥ 1 |
<1 |
≥ 1 |
<1 |
≥ 1 |
<1 |
|
|
|
||||||
|
SH |
15 (100%) |
0 (0%) |
22 (100%) |
0 (0%) |
24 (100%) |
0 (0%) |
|
CH |
11 (68.8%) |
5 (31.2%) |
4 (36.4%) |
7 (63.6%) |
2 (15.4%) |
11 (84.6%) |
|
AH |
2 (13.3%) |
13 (86.7%) |
1 (7.7%) |
12 (92.3%) |
1 (7.1%) |
13 (92.9%) |
|
WDA |
0 (0%) |
9 (100%) |
0 (0%) |
8 (100%) |
0 (0%) |
3 (100%) |
|
Total |
28 (50.9%) |
27 (50%) |
27 (50%) |
27 (50%) |
27 (50%) |
27 (50%) |
|
|
||||||
|
SH: Simple Hyperplasia, CH: Complex Hyperplasia, AH: Atypical Hyperplasia, WDA: Well Differentiated Adenocarcinoma. |
||||||
|
Izadi-Mood et al. Diagnostic Pathology 2009 4:10 doi:10.1186/1746-1596-4-10 |
||||||
